Ainos (NASDAQ:AIMD) vs. Intchains Group (NASDAQ:ICG) Head-To-Head Analysis

Ainos (NASDAQ:AIMD) and Intchains Group (NASDAQ:ICG) are both small-cap technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Valuation and Earnings

This table compares Ainos and Intchains Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$13,600.00	757.40	-$14.77 million	($2.52)	-0.55
Intchains Group	$31.58 million	1.92	-$6.80 million	($0.12)	-8.33

Intchains Group has higher revenue and earnings than Ainos. Intchains Group is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Ainos and Intchains Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ainos	-11,912.10%	-217.50%	-67.87%
Intchains Group	-24.68%	-5.29%	-5.08%

Risk & Volatility

Ainos has a beta of 2.47, indicating that its stock price is 147% more volatile than the S&P 500. Comparatively, Intchains Group has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Ainos and Intchains Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	1	0	0	0	1.00
Intchains Group	1	1	2	0	2.25

Intchains Group has a consensus target price of $2.50, indicating a potential upside of 150.00%. Given Intchains Group’s stronger consensus rating and higher possible upside, analysts plainly believe Intchains Group is more favorable than Ainos.

Summary

Intchains Group beats Ainos on 9 of the 12 factors compared between the two stocks.

About Ainos

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women’s health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

About Intchains Group

Intchains Group Limited designs and sells application-specific integrated circuit chips for blockchain applications in the People's Republic of China. The company also offers ancillary software, hardware, and other products. It serves distributors. Intchains Group Limited was founded in 2017 and is based in Pudong, China.